You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

FGF19 advanced tumor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumor-Derived FGF19

Recruiting
  • Colorectal Cancer
  • +2 more
    • Orlando, Florida
      Burnett School Biomedical Sciences
    Sep 28, 2023

    Solid Tumor, FGF Receptor Gene Mutation, FGF Amplification Trial in Tianjin (Pemigatinib)

    Recruiting
    • Solid Tumor
    • +4 more
    • Tianjin, Tianjin, China
      Tianjin Medical University Second Hospital
    Aug 28, 2023

    Advanced Hepatocellular Carcinoma, BCLC Stage A Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma Trial in

    Recruiting
    • Advanced Hepatocellular Carcinoma
    • +4 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 30, 2023

    Solid Tumor, Adult Trial (CF33-CD19 IT, CF33-CD19 IV, Blinatumomab)

    Not yet recruiting
    • Solid Tumor, Adult
    • CF33-CD19 IT
    • +2 more
    • (no location specified)
    Sep 26, 2023

    Advanced Solid Tumor Trial in Shanghai (SY-4798)

    Recruiting
    • Advanced Solid Tumor
    • Shanghai, China
      Shanghai East Hospital
    Aug 10, 2022

    Solid Tumor Trial in Tianjin (Pemigatinib)

    Completed
    • Solid Tumor
    • Tianjin, China
      Cancer Hospital of Tianjin Medical University
    Jul 22, 2021

    Solid Tumor, Adult, NSCLC, Advanced Cancer Trial (Adagrasib, nab-Sirolimus)

    Not yet recruiting
    • Solid Tumor, Adult
    • +4 more
    • (no location specified)
    Apr 24, 2023

    Advanced Solid Tumor Trial in Beijing (ICP-192)

    Recruiting
    • Advanced Solid Tumor
    • Bengbu, Anhui, China
    • +36 more
    Jan 3, 2023

    Advanced Solid Tumors Amenable to Anthracycline Therapy, Sarcoma, Breast Cancer, Lung Carcinomas, and Gynecological Cancer

    Completed
    • Advanced Solid Tumors Amenable to Anthracycline Therapy
    • Sarcoma, Breast Cancer, Lung Carcinomas, and Gynecological Cancer Amenable to Anthracycline Therapy
    • Münster, Germany
    • +1 more
    Apr 1, 2022

    Soft Tissue Sarcoma Trial in Münster (Dacarbazine, onfekafusp alfa)

    Recruiting
    • Soft Tissue Sarcoma
    • Bordeaux, France
    • +15 more
    Dec 22, 2022

    SARS-CoV-2 (COVID-19) Infection, Advanced or Metastatic Hematological or Solid Tumor Trial in France (Autophagy inhibitor

    Completed
    • SARS-CoV-2 (COVID-19) Infection
    • Advanced or Metastatic Hematological or Solid Tumor
    • Autophagy inhibitor (GNS651)
    • +3 more
    • Lyon, Rhône, France
    • +11 more
    Sep 29, 2022

    Hepatocellular Carcinoma Trial (ABSK-011 180 mg QD combined with atilizumab 1200 mg q3w)

    Not yet recruiting
    • Hepatocellular Carcinoma
    • ABSK-011 180 mg QD combined with atilizumab 1200 mg q3w
    • (no location specified)
    Jun 28, 2022

    Malignant Pleural Effusion, Malignant Pleural Mesothelioma, Mesothelioma Trial in Leicester (RSO-021)

    Recruiting
    • Malignant Pleural Effusion
    • +3 more
    • Leicester, United Kingdom
    • +5 more
    Oct 28, 2022

    Soft Tissue Sarcoma Trial in Santa Monica (L19TNF, DOXORUBICIN)

    Active, not recruiting
    • Soft Tissue Sarcoma
    • Santa Monica, California
      Sarcoma Oncology Research Center (SORC) Cancer Center of Souther
    Apr 19, 2022

    Soft Tissue Sarcoma Trial in Worldwide (Onfekafusp alfa, Doxorubicin)

    Recruiting
    • Soft Tissue Sarcoma
    • Bad Saarow, Germany
    • +8 more
    Apr 8, 2022

    Tumor With Alterations of the FGF-R Trial in China, Japan (BGJ398)

    Completed
    • Tumor With Alterations of the FGF-R
    • Guangzhou, Guangdong, China
    • +7 more
    Dec 6, 2020

    Unresectable Locally Advanced or Metastatic Pancreatic Cancer Trial in Shanghai (surufatinib, KN046, gemcitabine)

    Not yet recruiting
    • Unresectable Locally Advanced or Metastatic Pancreatic Cancer
    • Shanghai, Shanghai, China
      Zhongshan Hospital
    Apr 16, 2023

    Diffuse Large B Cell Lymphoma, Primary Mediastinal Lymphoma, Mantle Cell Lymphoma Trial in Tucson, Tampa, New York

    Completed
    Has Results
    • Diffuse Large B Cell Lymphoma
    • +4 more
    • Tucson, Arizona
    • +2 more
    Mar 23, 2021

    Nectin4-positive Advanced Malignant Solid Tumor Trial in Lishui, Wenzhou (CAR-T therapy for nectin4-positive malignant solid

    Unknown status
    • Nectin4-positive Advanced Malignant Solid Tumor
    • CAR-T therapy for nectin4-positive malignant solid tumor
    • Lishui, Zhejiang, China
    • +1 more
    Nov 16, 2020

    Hepatocellular Carcinoma (HCC) Trial in Worldwide (Fisogatinib (BLU-554))

    Active, not recruiting
    • Hepatocellular Carcinoma (HCC)
    • Fisogatinib (BLU-554)
    • Rialto, California
    • +40 more
    Aug 12, 2022

    Untreated Advanced or Recurrent Thymic Carcinomas Trial in Chuo (MK-3475, Lenvatinib, Carboplatin)

    Not yet recruiting
    • Untreated Advanced or Recurrent Thymic Carcinomas
    • Chuo, Tokyo, Japan
      National Cancer Center Hospital
    Apr 16, 2023

    Preoperative Serum FGF19 in the Prognosis of Biliary Atresia

    Not yet recruiting
    • Biliary Atresia
    • Prognosis
      • Shanghai, Shanghai, China
        Children's Hospital of Fudan University
      Apr 28, 2023

      Klotho _ LRP-6 _ Gastric Adenocarcinoma

      Not yet recruiting
      • Gastric Adenocarcinoma
      • +2 more
      • Prognostic study
      • (no location specified)
      Jan 29, 2023

      FGF19 in Obstructive Cholestasis: "Unveil the Signal"

      Recruiting
      • Cholestasis
      • +4 more
      • Biospecimen sampling
      • Aachen, Germany
        RWTH Aachen
      Feb 6, 2023

      Solid Tumor Trial in Italy, United States (Derazantinib low dose range, Derazantinib middle dose range, Derazantinib high dose

      Completed
      Has Results
      • Solid Tumor
      • Derazantinib low dose range
      • +3 more
      • Scottsdale, Arizona
      • +11 more
      Mar 7, 2022